Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
BMC Res Notes ; 12(1): 584, 2019 Sep 18.
Artigo em Inglês | MEDLINE | ID: mdl-31533801

RESUMO

OBJECTIVE: The aim of this study was to compare in vivo effect of five pharmacological options on inflammation and pulmonary fibrosis induced by paraquat. METHODS: 54 Wistar SPF rats were used. After 2 h post-intoxication with paraquat ion, groups of 9 animals were randomly assigned to (1) cyclophosphamide plus dexamethasone (2) low molecular weight heparin (3) unfractionated heparin (4) vitamin C every 24 h, (5) atorvastatin or (6) placebo with intraperitoneal saline. Lung inflammation, alveolar injury, hepatocyte damage, hepatic regeneration, acute tubular necrosis and kidney congestion were evaluated. RESULTS: In the control group 100% of animals presented moderate and severe lung inflammation, while in the groups with atorvastatin and intratracheal heparin this proportion was lower (55.5%; CI 26.6-81.3%) (p = 0.025). A lower degree of moderate or severe hepatic regeneration was evident in the treatment groups with atorvastatin (p = 0.009). In this study was demonstrated that statins and heparin might have a protective effect in the paraquat-induced destructive phase. More evidence is needed to evaluated of dose-response effects of these drugs before to study in clinical trials.


Assuntos
Tratamento Farmacológico/métodos , Pulmão/efeitos dos fármacos , Pneumonia/tratamento farmacológico , Alvéolos Pulmonares/efeitos dos fármacos , Fibrose Pulmonar/tratamento farmacológico , Animais , Antioxidantes/farmacologia , Ácido Ascórbico/farmacologia , Atorvastatina/farmacologia , Ciclofosfamida/farmacologia , Dexametasona/farmacologia , Quimioterapia Combinada , Heparina/farmacologia , Heparina de Baixo Peso Molecular/farmacologia , Pulmão/patologia , Paraquat/toxicidade , Pneumonia/patologia , Alvéolos Pulmonares/patologia , Fibrose Pulmonar/induzido quimicamente , Ratos Wistar , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA